Findings from several studies suggest that apelin treatment during insulin resistance triggers a number of coordinated beneficial effects, including reduction of hyperinsulinemia and adiposity, and stimulation of glucose uptake and fuel consumption [8]. This evidence concerns the gene APLN and hyperinsulinism.